Chapman University in Orange is teaming with the Keck Graduate Institute of Applied Life Sciences in Claremont to start a biopharmacy school.
The Chapman-KGI School of BioPharmacy will provide pharmacists with additional post-graduate training in biotechnology.
It is expected to open in 2014 at the campus of the Keck Graduate Institute, which is part of the Claremont Colleges, a consortium of undergraduate and graduate schools. Chapman is expected to begin hosting classes at its main campus once it completes the construction of a 120,000-square-foot Science Center. The new facility also will house Chapman’s Schmid College of Science and Technology.
The program will blend Keck Graduate Institute’s master and postdoctoral programs in biotechnology and Chapman’s computational sciences programs.
The new school will focus on the developments in the pharmacogenomics field—the study of how individuals’ genetics affect their bodies’ responses to drugs. Its curriculum will include course work in therapeutics, therapy management and regulatory affairs involving biotechnology and pharmaceutical companies, among other areas.
The two schools are on a search for a founding dean.